Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico

International Journal of Drug Policy

Volumn 20, Issue 4, 2009, Pages 329-335

  Philbin, Morgan M ^a   Mantsios, Andrea ^a   Lozada, Remedios ^b   Case, Patricia ^c   Pollini, Robin A ^a   Alvelais, Jorge ^b   Latkin, Carl A ^d   Magis Rodriguez, Carlos ^e   Strathdee, Steffanie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pro COMUSIDA   (Mexico)

^c FENWAY INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Ministry of Health   (Mexico)

Author keywords

Harm reduction; HIV AIDS; Injection drug use; Mexico

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DECISION MAKING; DISEASE TRANSMISSION; HARM REDUCTION; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INJECTION; INSTRUMENT STERILIZATION; INTERVIEW; INTRAVENOUS DRUG ABUSE; LAW ENFORCEMENT; MEXICO; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SYRINGE;

ADULT; AGED; ATTITUDE; FEASIBILITY STUDIES; FEMALE; HARM REDUCTION; HEALTH PERSONNEL; HUMANS; INTERVIEWS AS TOPIC; LAW ENFORCEMENT; MALE; MEXICO; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; PHARMACISTS; POLITICS; RELIGION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 67349268780     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.09.002     Document Type: Article

References (49)

1. Bluthenthal R.N., Heinzerling K.G., Anderson R., Flynn N.M., and Kral A.H. Approval of syringe exchange programs in California: Results from a local approach to HIV prevention. American Journal of Public Health 98 2 (2008) 278-283
2. Brouwer K.C., Lozada R., Cornelius W.A., Firestone-Cruz M., Magis-Rodriguez C., Zuniga M.L., et al. Deportation Along the U.S.-Mexico Border: Its Relation to drug use patterns and accessing care. Journal of Immigrant and Minority Health. (2008) February 5
3. Brouwer K.C., Strathdee S., Magis-Rodriguez C., Bravo-Garcia E., Gayet C., and Patterson T. Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. Journal of Urban Health 83 2 (2006) 299-301
4. CENSIDA (2003). El consumo de drogas inyectadas y la epidemia del VIH/SIDA en Mexico. Un Problema de Salud Publica: Documento de posicion. Retrieved November 3rd 2007, from http://www.salud.gob.mx/conasida/noticias/vihsidacarceles/posicion.doc.
5. CENSIDA (2006). Actividades de reddución del daño en usuarios de drogas: Informe interno. Retrieved 2nd November 2007, from http://www.salud.gob.mx/conasida.
6. Consejo Nacional Contra las Adicciones (CONADIC) (1998). Diagnóstico y Tendencias del Uso de Drogas en México: Results from the National Survey on addictions: 1998 Data. Retrieved 15th November 2007 from: http://www.salud.gob.mx/unidades/cdi/documentos/CDM1-2.htm
7. Downing M., Riess T.H., Vernon K., Mulia N., Hollinquest M., McKnight C., et al. What's community got to do with it? Implementation models of syringe exchange programs. AIDS Education and Prevention 17 1 (2005) 68-78
8. Firestone-Cruz M., Mantsios A., Ramos R., Case P., Brouwer K.C., Ramos M.E., et al. A qualitative exploration of gender in the context of injection drug use in two-US-Mexico border cities. AIDS and Behavior 11 2 (2006) 253-262
9. Friedman S.R., Perlis T., and DesJarlais D.C. Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health 91 5 (2001) 791-793
10. Frost S.D.W., Brouwer K.C., Firestone-Cruz M.A., Ramos R., Ramos M.E., Lozada R.M., et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health 83 6 Suppl (2006) i83-97
11. Garcia S.G., Tatum C., Becker D., Swanson K., Lockwood K., and Ellertson C. Policy implications of a national public opinion survey on abortion in Mexico. Reproductive Health Matters 12 24 (2004) 65-74
12. Hagan H., McGough J., Thiede H., Hopkins S., Duchin J., and Alexander E. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 19 3 (2000) 247-252
13. Hansen H. Isla evangelista-a story of church and state: Puerto Rico's faith-based initiatives in drug treatment. Culture of Medical Psychiatry 29 4 (2005) 433-456
14. Henderson L., Vlahov D., Celentano D., and Strathdee S.A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. Journal of Acquired Immune Deficiency Syndromes 32 2 (2003) 229-237
15. Kerr T., Oleson M., Tyndall M., Montaner J., and Wood E. A description of a peer-run supervised injection site for injection drug users. Journal of Urban Health 82 2 (2005) 267-275
16. Kerr T., Tyndall M., Li K., Montaner J., and Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 366 9482 (2005) 316-318
17. Kitsenko G., Shakhov A., Lazzarini Z., Case P., Chintalova-Dallas R., and Burris S. Harm reduction training in law schools in Ukraine. Proceedings of the 19th international harm reduction conference (IHRC). Barcelona, Spain, May 11-15 (2008)
18. Kozachenko N., Darbekova G., Mingazova I., Burris S., Case P., Chintalova-Dallas R., et al. Evaluation of drug policy and HIV/AIDS prevention programs in Kazakhstan (Temirtau and Shymkent): Summary of RPA results. Proceeding of the 19th international harm reduction conference (IHRC). Barcelona, Spain, May 11-15 (2008)
19. Kuo I., Brady J., Butler C., Schwartz R., Brooner R., and Vlahov D. Feasibility of referring drug users from a needle exchange program into an addiction treatment program: Experience with a mobile treatment van and LAAM maintenance. Journal of Substance Abuse Treatment 24 1 (2003) 67-74
20. Lazzarini Z., Case P., Burris S., and Chintalova-Dallas R. Three easy policy changes to improve the risk environment for IDUs in Eastern Europe and the former Soviet Union. Abstract #970. Proceedings of the 18th International Harm Reduction Conference. Warsaw, Poland, May 13-17 (2007) (oral presentation)
21. Magis-Rodriguez C., Bravo-Garcia E., and Rivera Reyes P. La respuesta Mexicana al SIDA: Mejores practicas. In: Uribe P., and Magis C. (Eds). Angulos del SIDA 2000 (2000), Consejo Nacional para la Prevención y Control del SIDA, México D.F., Mexico
22. Magis-Rodriguez C., Marques L.F., and Touze G. HIV and injection drug use in Latin America. AIDS 16 Suppl 3 (2002) 34-41
23. Magis-Rodriguez C., Ortiz Ruiz L., and Ortiz Mondragon R. Actividades de reducción del daño en usuarios de drogas: Informe interno 2006 (2007), Centro Nacional Para La, Mexico City
24. Normand J., Vlahov D., and Moses L.E. Preventing HIV transmission: The role of sterile needles and bleach (1995), National Academy Press, Washington, DC
25. Obadia Y., Feroni I., Perrin V., VLahov D., and Moatti J.P. Syringe vending machines for injection drug users: An experiment in Marseille, France. American Journal of Public Health 89 12 (1999) 1852-1854
26. Powers R. The role of qualitative research in HIV/AIDS. AIDS 12 7 (1998) 687-695
27. Reid G., Kamarulzaman A., and Sran S.K. Malaysia and harm reduction: The challenges and responses. International Journal of Drug Policy 18 2 (2007) 136-140
28. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., and Hickman M. Public injecting and the need for 'safer environment interventions; in the reduction of drug-related harm. Addiction 101 10 (2006) 1384-1393
29. Rhodes T., Singer M., Bourgois P., Friedman S., and Strathdee S. The social structural production of HIV risk among injecting drug users. Social Science and Medicine 61 5 (2005) 1026-1044
30. Sobeyko J., Duklas T., Parczewski M., Leszczyszyn-Pynka M., Bejnarowicz P., Lazzarini Z., et al. After the rapid policy and response process: Drug policy change in Szczecin, Poland. Abstract #668. Proceedings of the 18th international harm reduction conference. Warsaw, Poland, May 13-17 (2007) (poster presentation)
31. Strathdee S.A., Fraga W.D., Case P., Firestone M., Brouwer K.C., and Perez S.G. Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: High-risk injection behaviors in Tijuana, Mexico. Journal of Urban Health 82 3 Suppl 4 (2005) iv58-73
32. Strathdee S.A., Lozada R., Pollini R.A., Brouwer K.C., Mantsios A., Abramovitz D.A., et al. Individual, social, and environmental influences associated with HIV infection among IDUs in Tijuana. Journal of Acquired Immune Deficiency Syndrome 47 3 (2008) 369-376
33. Strathdee S.A., and Magis-Rodriguiz C. Mexico's evolving HIV epidemic. Journal of American Medical Association 300 5 (2008) 571-573
34. Strathdee S.A., Philbin M.M., Semple S.J., Pu M., Orozovich P., Martinez G., et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug and Alcohol Dependence 92 1-3 (2008) 132-140
35. Strathdee S.A., and Vlahov D. The effectiveness, of needle exchange programmes: A review of the science and policy. AIDS Science 1 16 (2001) 1-33
36. Sullivan S., and Wu Z. Rapid scale up of harm reduction in China. International Journal of Drug Policy 18 2 (2007) 118-128
37. Tashima N., Crain C., O'Reilly K., and Elifson C. The community identification (CID) process: A discovery model. Qualitative Health Research 6 1 (1996) 23-48
38. Tempalski B. Placing the dynamics of syringe exchange programs in the United States. Health and Place 13 2 (2007) 417-431
39. Tempalski B., Flom P.L., Friedman S., Des Jarlais R., Friedman D.C., McKnight J.J., et al. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. American Journal of Public Health 97 3 (2007) 437-447
40. Tkatchenko-Schmidt E., Renton A., Gevorgyan R., Davydenko L., and Atun R. Prevention of HIV/AIDS among injecting drug users in Russia: Opportunities and barriers to scaling-up of harm reduction programmes. Health Policy 85 2 (2008) 162-171
41. UNAIDS. AIDS epidemic update (2007), UNAIDS, Geneva, Switzerland. http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive /2007default.asp
42. U.S. State Department. (2006). International religious freedom report (2006) Released by the Bureau of Democracy. Human Rights, and Labor. Retrieved 10th December 2007 from http://www.state.gov/g/drl/rls/irf/2006/71467.htm.
43. Viani R., Araneta M., Ruiz-Calderon J., Hubbard P., Lopez G., and Chacon-Cruz E. Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico. Journal Acquired Immune Deficiency Syndrome 41 1 (2006) 87-92
44. Vlahov D., Des Jarlais D., Goosby E., Hollinger P., Lurie P., and Shriver M. Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy. American Journal of Epidemiology 154 12 (2001) S70-S77
45. Vyshemirskaya I., Osipenko V., Burkhanova O., Lazzarini Z., Burris S., Chintalova-Dallas R., et al. Initiating practical health interventions for IDUs in Kaliningrad, Russia: Results of a rapid policy assessment and response (RPAR). Proceedings of the 19th international harm reduction conference (IHRC). Barcelona, Spain, May 11-15 (2008)
46. Wodak A. Controlling HIV among injecting drug users: The current status of harm reduction. HIV/AIDS Policy and Law Review 11 2/3 (2006) 77-80
47. Wood E., Kerr T., Lloyd-Smith E., Buchner C., Marsh D., and Montaner J. Methodology for evaluating insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal 1 1 (2004) 9
48. Wood E., Kerr T., Tyndall M.W., Zhang R., Hogg R.S., Strathdee S.A., et al. Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Addiction 102 9 (2007) 1503-1505
49. Wynia K.A. Science, faith, and AIDS: The battle of harm reduction. American Journal of Bioethics 5 2 (2005) 3-4